Resmed (RMD) Amortization of Deferred Charges (2019 - 2021)

Resmed (RMD) has reported Amortization of Deferred Charges for 3 consecutive years, with $8.5 million the latest figure, recorded in Q3 2021.

• For the quarter ending Q3 2021, Amortization of Deferred Charges fell 18.28% year-over-year to $8.5 million; the trailing twelve-month figure through Sep 2021 stood at $32.9 million (up 6.05% YoY), and the FY2021 full-year result was $34.8 million, up 31.06% from the prior year.
• Amortization of Deferred Charges fell to $8.5 million in Q3 2021 per RMD's latest filing, from $9.0 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $10.4 million in Q3 2020 and bottomed at $6.0 million in Q3 2019.
• Historically, Amortization of Deferred Charges has averaged $7.8 million across 3 years, with a median of $7.5 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Amortization of Deferred Charges soared 74.78% in 2020, then dropped 18.28% in 2021.
• Over 3 years, Amortization of Deferred Charges stood at $6.4 million in 2019, then grew by 17.75% to $7.5 million in 2020, then climbed by 13.73% to $8.5 million in 2021.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $8.5 million, $9.0 million, and $7.9 million for Q3 2021, Q2 2021, and Q1 2021 respectively.